GFM
MESO

GF Fund Management’s Mesoblast MESO Stock Holding History

GF Fund Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
1,109
+16
+1% +$238 ﹤0.01% 505
2026
Q1 		$16.8K Buy
1,093
+129
+13% +$2.15K ﹤0.01% 517
2025
Q4 		$17.4K Sell
964
-52
-5% -$895 ﹤0.01% 523
2025
Q3 		$16.4K Buy
1,016
+199
+24% +$2.91K ﹤0.01% 513
2025
Q2 		$8.9K Hold
817
– – ﹤0.01% 581
2025
Q1 		$10.2K Buy
817
+146
+22% +$2.4K ﹤0.01% 561
2024
Q4 		$13.3K Buy
+671
New +$7.43K ﹤0.01% 512

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

GF Fund Management's MESO Position: Q2 2026 in Review

GF Fund Management increased its Mesoblast (MESO) stake by 1.5% in Q2 2026, buying an estimated $238 and bringing the position to 1,109 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

GF Fund Management first reported a position in MESO in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.4K in Q4 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • GF Fund Management held 1,109 shares of Mesoblast worth $15K as of Q2 2026.
  • GF Fund Management bought 16 Mesoblast shares in Q2 2026, an estimated $238.
  • Mesoblast made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #505 holding.
  • GF Fund Management first reported a position in Mesoblast in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Mesoblast position peaked at $17.4K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.